2 weeks ago
UPSC Key: Gene Therapy, Tribunals, Nuclear Rules and Trade
A new experimental treatment tries to lower bad cholesterol with one gene-editing infusion instead of daily medicines, but doctors still need to study its long-term safety.
India has also passed a Bill to change how tribunals, which settle specialised disputes, are managed.
The Bill creates a National Tribunals Commission, although the government would still retain some powers.
New nuclear rules may help Russia because Russian reactor technology is already operating, while many rival designs are still awaiting approval.
India’s buffalo-meat exports increased sharply and reached a record value.
Public sector banks were asked to become easier and more attractive for young people to use.
Donations to the PM CARES Fund decreased, but its closing balance reached a record high because spending was very low.
BRICS countries criticised the European Union’s carbon import levy, saying it could hurt developing countries.
The USS Abraham Lincoln aircraft carrier remained at sea for more than eight months, prompting reports about difficult living conditions and crew morale.
Eli Lilly and Verve Therapeutics’ experimental VERVE-102 gene-editing therapy lowered LDL cholesterol by about 62% for up to 18 months in a phase 1 trial.
The Tribunals Reforms Bill, 2026, proposes a National Tribunals Commission, five-year tenures and a three-month deadline for government appointments.
Draft SHANTI Act rules require imported nuclear technology to be approved and operational in its country of origin, potentially strengthening Russia’s advantage in India.
India’s buffalo-meat exports rose to $5.1 billion in 2025-26, while PM CARES Fund contributions and spending fell during the same period.
BRICS environment ministers opposed the EU’s Carbon Border Adjustment Mechanism, while India’s public sector banks were urged to attract younger customers and improve financial inclusion.
- Who
- Eli Lilly and Verve Therapeutics, Parliament, the Union government, Russia’s Rosatom, Indian public sector banks, the PM CARES Fund trustees and BRICS environment ministers are among the principal actors discussed.
- What
- The roundup covers experimental cholesterol gene editing, tribunal reforms, nuclear-energy rules, banking and financial inclusion, buffalo-meat exports, PM CARES finances, aircraft-carrier deployment and opposition to the EU’s carbon border tax.
- Where
- The developments involve India, the Arabian Sea, the European Union, BRICS countries, Russia, China and other international markets.
- When
- The material concerns developments reported for August 19, 2026, with some events and financial figures covering 2025-26 and April-June 2026.
- Why
- They are presented as current-affairs topics relevant to the UPSC Civil Services Preliminary and Main examinations.
Critics, courts and developing countries
Governments, institutions and industry supporters
Tribunal administration
Critics, courts and developing countries
The Supreme Court has argued that executive control over appointments, funding and administration can undermine tribunal independence and has pressed for an independent commission.
Governments, institutions and industry supporters
The Union government says the 2026 Bill improves efficiency, independence, transparency and uniformity, while retaining administrative powers it considers necessary.
Nuclear liability and market access
Critics, courts and developing countries
Critics may view liability caps, the absence of statutory supplier exposure and greater residual state responsibility under SHANTI as reducing accountability after a nuclear accident.
Governments, institutions and industry supporters
The government presents a pragmatic liability framework and greater private and foreign participation as necessary to help India pursue its target of 100 GW of nuclear capacity by 2047.
European carbon border levy
Critics, courts and developing countries
BRICS ministers called CBAM unilateral, punitive, discriminatory and protectionist, arguing that it could burden developing countries and conflict with climate-equity principles.
Governments, institutions and industry supporters
The European Union’s stated rationale is to price embedded emissions, prevent carbon leakage, protect European industries facing stricter standards and reduce global emissions.
Key facts
- VERVE-102 result
- A phase 1 trial reported an approximately 62% reduction in LDL cholesterol lasting as long as 18 months after a single infusion.
- Tribunal Commission
- The 2026 Bill establishes a National Tribunals Commission to oversee selection, performance review, complaints and tribunal data.
- Tribunal tenure
- Chairpersons and members would generally serve five-year terms, with maximum ages of 70 and 67 years respectively.
- Nuclear technology rule
- Imported foreign nuclear technology must be certified or approved by the regulator in its country of origin and already operational in India or another foreign country.
- Buffalo-meat exports
- Exports reached $5.1 billion in 2025-26, up 25.6%, and increased 66.6% year-on-year during April-June 2026.
- PM CARES finances
- Contributions fell to Rs 479.96 crore in 2024-25, while the closing balance reached Rs 8,452.06 crore and spending fell to Rs 87.85 lakh.
- Financial inclusion
- The RBI Financial Inclusion Index rose from 43.4 in March 2017 to 70.0 in March 2026.
- CBAM
- The European Union’s Carbon Border Adjustment Mechanism entered its full implementation phase on January 1, 2026, requiring importers to surrender carbon-linked certificates.
Quotes
Prime Minister
Prime Minister Narendra Modi, acting as ex‑officio chairman of the PM‑CARES Fund
“"In the last couple of years, we have consciously worked at making Indian buffalo meat a global brand and not a number two alternative to cattle beef."”
indianexpress.com
“"The PM‑CARES Fund’s closing balance has reached an all‑time high of Rs 8,452.06 crore, even as spending has fallen to a five‑year low."”
indianexpress.com
Professor David E Newby
British Heart Foundation Duke of Edinburgh Chair of Cardiology and co‑author of the VERVE‑102 trial
“"In traditional treatment, you keep taking the medicine to keep the effect of lowering LDL. In VERVE‑102, you make a one‑time targeted change to DNA inside liver cells to keep the effect going."”
indianexpress.com










